Melissa Wake

Last updated

Melissa Wake
Professor Melissa Anne Wake- Generation Victoria (headshot, 2020).jpg
Alma mater
Scientific career
Fields Paediatrics, Community child health, epidemiology, longitudinal studies, population health, clinical trials
InstitutionsMurdoch Children's Research Institute, University of Melbourne, University of Auckland

Melissa Anne Wake is a New Zealand paediatrician and scientific director of the Generation Victoria initiative, [1] which states the aim of creating very large, parallel whole-of-state birth and parent cohorts in Victoria, Australia, for Open Science discovery and interventional research. [2] She is group leader of the Murdoch Children's Research Institute's Prevention Innovation Research Group [3] and holds professorial positions with the University of Melbourne and the University of Auckland (the Liggins Institute). [4] [5]

Contents

Her "population paediatrics" research spans common childhood conditions and antecedents of diseases of ageing. [6] [7] She leads the Longitudinal Study of Australian Children's biophysical repository (the Child Health CheckPoint) [6] and has led or co-led 20 community-based randomised trials. A major focus is on building large-scale platforms to support faster, better observational and interventional children's research. [6]

Early life and education

Melissa Wake was born in Levin, New Zealand, the youngest of five children. After leaving Woodford House School for Girls in 1976, she graduated in medicine from the University of Otago in 1982, and entered clinical paediatrics in England before formal training in Auckland and Melbourne. Following her research doctorate (1999), she was Director of Research at Melbourne's Centre for Community Child Health [8] and a consultant paediatrician at Melbourne Royal Children's Hospital. In 2017, she took up the Chair in Child Health Research at the University of Auckland, later returning to Melbourne to lead the foundational stages of Generation Victoria. [9]

Awards

Publications

Wake (ORCiD: 0000-0001-7501-9257) has published nearly 400 journal articles including:

Randomised and quasi-experimental trials

Data resources and cohort research

Related Research Articles

Evidence-based medicine (EBM) is "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. ... [It] means integrating individual clinical expertise with the best available external clinical evidence from systematic research." The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management. The term was originally used to describe an approach to teaching the practice of medicine and improving decisions by individual physicians about individual patients.

<span class="mw-page-title-main">Obesity</span> Medical condition in which excess body fat harms health

Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it can potentially have negative effects on health. People are classified as obese when their body mass index (BMI)—a person's weight divided by the square of the person's height—is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower values to calculate obesity. Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis.

<span class="mw-page-title-main">Type 2 diabetes</span> Form of diabetes mellitus

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Other symptoms include increased hunger, having a sensation of pins and needles, and sores (wounds) that heal slowly. Symptoms often develop slowly. Long-term complications from high blood sugar include heart disease, stroke, diabetic retinopathy, which can result in blindness, kidney failure, and poor blood flow in the lower-limbs, which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Randomized controlled trial</span> Form of scientific experiment

A randomized controlled trial is a form of scientific experiment used to control factors not under direct experimental control. Examples of RCTs are clinical trials that compare the effects of drugs, surgical techniques, medical devices, diagnostic procedures, diets or other medical treatments.

<span class="mw-page-title-main">Cardiovascular disease</span> Class of diseases that involve the heart or blood vessels

Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.

In clinical trials, a surrogate endpoint is a measure of effect of a specific treatment that may correlate with a real clinical endpoint but does not necessarily have a guaranteed relationship. The National Institutes of Health (USA) defines surrogate endpoint as "a biomarker intended to substitute for a clinical endpoint".

<span class="mw-page-title-main">Women's Health Initiative</span> Long-term U.S. health study

The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS). In particular, randomized controlled trials were designed and funded that addressed cardiovascular disease, cancer, and osteoporosis.

<span class="mw-page-title-main">Sedentary lifestyle</span> Type of lifestyle involving little or no physical activity

Sedentary lifestyle is a lifestyle type, in which one is physically inactive and does little or no physical movement and/or exercise. A person living a sedentary lifestyle is often sitting or lying down while engaged in an activity like socializing, watching TV, playing video games, reading or using a mobile phone or computer for much of the day. A sedentary lifestyle contributes to poor health quality, diseases as well as many preventable causes of death.

Necrotizing enterocolitis (NEC) is an intestinal disease that affects premature or very low birth weight infants. Symptoms may include poor feeding, bloating, decreased activity, blood in the stool, vomiting of bile, multi-organ failure, and potentially death.

<span class="mw-page-title-main">Systematic review</span> Comprehensive review of research literature using systematic methods

A systematic review is a scholarly synthesis of the evidence on a clearly presented topic using critical methods to identify, define and assess research on the topic. A systematic review extracts and interprets data from published studies on the topic, then analyzes, describes, critically appraises and summarizes interpretations into a refined evidence-based conclusion. For example, a systematic review of randomized controlled trials is a way of summarizing and implementing evidence-based medicine.

A hierarchy of evidence, comprising levels of evidence (LOEs), that is, evidence levels (ELs), is a heuristic used to rank the relative strength of results obtained from experimental research, especially medical research. There is broad agreement on the relative strength of large-scale, epidemiological studies. More than 80 different hierarchies have been proposed for assessing medical evidence. The design of the study and the endpoints measured affect the strength of the evidence. In clinical research, the best evidence for treatment efficacy is mainly from meta-analyses of randomized controlled trials (RCTs). Systematic reviews of completed, high-quality randomized controlled trials – such as those published by the Cochrane Collaboration – rank the same as systematic review of completed high-quality observational studies in regard to the study of side effects. Evidence hierarchies are often applied in evidence-based practices and are integral to evidence-based medicine (EBM).

<span class="mw-page-title-main">Childhood obesity</span> Obesity in children

Childhood obesity is a condition where excess body fat negatively affects a child's health or well-being. As methods to determine body fat directly are difficult, the diagnosis of obesity is often based on BMI. Due to the rising prevalence of obesity in children and its many adverse health effects it is being recognized as a serious public health concern. The term overweight rather than obese is often used when discussing childhood obesity, as it is less stigmatizing, although the term overweight can also refer to a different BMI category. The prevalence of childhood obesity is known to differ by sex and gender.

In a randomized experiment, allocation concealment hides the sorting of trial participants into treatment groups so that this knowledge cannot be exploited. Adequate allocation concealment serves to prevent study participants from influencing treatment allocations for subjects. Studies with poor allocation concealment are prone to selection bias.

Immunization during pregnancy is the administration of a vaccine to a pregnant individual. This may be done either to protect the individual from disease or to induce an antibody response, such that the antibodies cross the placenta and provide passive immunity to the infant after birth. In many countries, including the US, Canada, UK, Australia and New Zealand, vaccination against influenza, COVID-19 and whooping cough is routinely offered during pregnancy.

Consolidated Standards of Reporting Trials (CONSORT) encompasses various initiatives developed by the CONSORT Group to alleviate the problems arising from inadequate reporting of randomized controlled trials. It is part of the larger EQUATOR Network initiative to enhance the transparency and accuracy of reporting in research.

<span class="mw-page-title-main">Obesity-associated morbidity</span> Medical condition

Obesity is a risk factor for many chronic physical and mental illnesses.

Management of obesity can include lifestyle changes, medications, or surgery. Although many studies have sought effective interventions, there is currently no evidence-based, well-defined, and efficient intervention to prevent obesity.

The relationship between antidepressant use and suicide risk is a subject of medical research and has faced varying levels of debate. This problem was thought to be serious enough to warrant intervention by the U.S. Food and Drug Administration to label greater likelihood of suicide as a risk of using antidepressants. Some studies have shown that the use of certain antidepressants correlate with an increased risk of suicide in some patients relative to other antidepressants. However, these conclusions have faced considerable scrutiny and disagreement: A multinational European study indicated that antidepressants decrease risk of suicide at the population level, and other reviews of antidepressant use claim that there is not enough data to indicate antidepressant use increases risk of suicide.

<span class="mw-page-title-main">Susan Jebb</span> British nutritionist

Susan Ann Jebb is Chair of the United Kingdom's Food Standards Agency and Professor of Diet and Population Health at the Nuffield Department of Primary Care Health Sciences, University of Oxford.

Peymané Adab is a British physician who is a Professor of Public Health at the University of Birmingham. She leads the Institute of Applied Health Research Chronic Disease Management Team. Adab investigates the epidemiology and management of obesity and chronic obstructive pulmonary disease.

References

  1. "Our Team". GenV. Generation Victoria. Retrieved 8 March 2023.
  2. "For Researchers". GenV. Generation Victoria. Retrieved 8 March 2023.
  3. "Prevention Innovation". MCRI. Murdoch Children's Research Institute. Retrieved 8 March 2023.
  4. "Melissa Wake Profile". The University of Auckland. Retrieved 8 March 2023.
  5. "Prof Melissa Wake". Find An Expert - UniMelb. The University of Melbourne. Retrieved 8 March 2023.
  6. 1 2 3 "Child Health CheckPoint". MCRI. Murdoch Children's Research Institute. Retrieved 8 March 2023.
  7. "Professor Melissa Wake". AAHMS. Australian Academy of Health and Medical Sciences. Retrieved 8 March 2023.
  8. 1 2 3 "Centre for Community Child Health". The Royal Children's Hospital. Retrieved 8 March 2023.
  9. "Our team". Generation Victoria. Retrieved 8 March 2023.
  10. "10 of the Best NHMRC research projects 2016" (PDF). NHMRC. Australian Government National Health and Medical Research Council. Archived from the original (PDF) on 16 April 2019. Retrieved 8 March 2023.
  11. Hiscock, H.; Wake, M. (2002). "Randomised controlled trial of behavioural infant sleep intervention to improve infant sleep and maternal mood". BMJ (Clinical Research Ed.). 324 (7345): 1062–1065. doi:10.1136/bmj.324.7345.1062. PMC   104332 . PMID   11991909.
  12. Wake, M.; Baur, L. A.; Gerner, B.; Gibbons, K.; Gold, L.; Gunn, J.; Levickis, P.; McCallum, Z.; Naughton, G.; Sanci, L.; Ukoumunne, O. C. (2009). "Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trial". BMJ (Clinical Research Ed.). 339: b3308. doi:10.1136/bmj.b3308. PMC   2737607 . PMID   19729418.
  13. Wake, M.; Tobin, S.; Girolametto, L.; Ukoumunne, O. C.; Gold, L.; Levickis, P.; Sheehan, J.; Goldfeld, S.; Reilly, S. (2011). "Outcomes of population based language promotion for slow to talk toddlers at ages 2 and 3 years: Let's Learn Language cluster randomised controlled trial". BMJ (Clinical Research Ed.). 343. BMJ: d4741. doi:10.1136/bmj.d4741. PMC   3191855 . PMID   21852344 . Retrieved 8 March 2023.
  14. Wake, M.; Lycett, K.; Clifford, S. A.; Sabin, M. A.; Gunn, J.; Gibbons, K.; Hutton, C.; McCallum, Z.; Arnup, S. J.; Wittert, G. (2013). "Shared care obesity management in 3-10 year old children: 12 month outcomes of HopSCOTCH randomised trial". BMJ (Clinical Research Ed.). 346. BMJ: f3092. doi:10.1136/bmj.f3092. PMC   3677741 . PMID   23751902 . Retrieved 8 March 2023.
  15. Sung, V.; Hiscock, H.; Tang, M. L.; Mensah, F. K.; Nation, M. L.; Satzke, C.; Heine, R. G.; Stock, A.; Barr, R. G.; Wake, M. (2014). "Treating infant colic with the probiotic Lactobacillus reuteri: Double blind, placebo controlled randomised trial". BMJ (Clinical Research Ed.). 348. BMJ Open: g2107. doi:10.1136/bmj.g2107. PMC   3972414 . PMID   24690625 . Retrieved 8 March 2023.
  16. Wake, M.; Ching, T. Y.; Wirth, K.; Poulakis, Z.; Mensah, F. K.; Gold, L.; King, A.; Bryson, H. E.; Reilly, S.; Rickards, F. (2016). "Population Outcomes of Three Approaches to Detection of Congenital Hearing Loss". Pediatrics. 137 (1). doi:10.1542/peds.2015-1722. PMC   4702017 . PMID   26704085.
  17. Roberts, G.; Quach, J.; Spencer-Smith, M.; Anderson, P. J.; Gathercole, S.; Gold, L.; Sia, K. L.; Mensah, F.; Rickards, F.; Ainley, J.; Wake, M. (2016). "Academic Outcomes 2 Years After Working Memory Training for Children With Low Working Memory: A Randomized Clinical Trial". JAMA Pediatrics. 170 (5): e154568. doi:10.1001/jamapediatrics.2015.4568. hdl: 10536/DRO/DU:30082811 . PMID   26954779 . Retrieved 8 March 2023.
  18. Wake, M.; Hesketh, K.; Lucas, J. (2000). "Teething and tooth eruption in infants: A cohort study". Pediatrics. 106 (6): 1374–1379. doi:10.1542/peds.106.6.1374. PMID   11099591 . Retrieved 8 March 2023.
  19. Williams, J.; Wake, M.; Hesketh, K.; Maher, E.; Waters, E. (2005). "Health-related quality of life of overweight and obese children". JAMA. 293 (1): 70–76. doi:10.1001/jama.293.1.70. hdl: 10536/DRO/DU:30006497 . PMID   15632338. S2CID   11614187 . Retrieved 8 March 2023.
  20. Clifford, S. A.; Davies, S.; Wake, M.; Child Health Checkpoint, Team (2019). "Child Health CheckPoint: Cohort summary of a physical health and biospecimen module for the Longitudinal Study of Australian Children". BMJ Open. 9 (Suppl 3): 3–22. doi:10.1136/bmjopen-2017-020261. PMC   6624028 . PMID   31273012 . Retrieved 8 March 2023.
  21. Hu, Yanhong Jessika; Wake, Melissa; Saffery, Richard (2021). "Clarifying the Sweeping Consequences of COVID-19 in Pregnant Women, Newborns, and Children with Existing Cohorts". JAMA Pediatrics. 175 (2): 117–118. doi:10.1001/jamapediatrics.2020.2395. PMID   32797150. S2CID   221132808 . Retrieved 8 March 2023.
  22. Wake, M.; Goldfeld, S.; Davidson, A. (2022). "Embedding Life Course Interventions in Longitudinal Cohort Studies: Australia's GenV Opportunity". Pediatrics. 149 (Suppl 5). doi:10.1542/peds.2021-053509R. PMC   9847412 . PMID   35503324.